VERAVera Therapeutics Inc - Ordinary Shares - Class A
$33.87
$0.22
(0.65%)
Pre-Market
EarningsAug 4
Mkt Cap$2.42B
Vol10,060.00
Fundamentals
Mkt Cap
$2.42B
Volume
-
52W High
$56.05
52W Low
$19.07
PE Ratio
-6.07
Avg. Volume
1M
EPS (Annual)
-$4.66
Rev/Employee
$0.00
Earnings
Aug 04
Pictet Asset Management Holding SA Cuts Stake in Vera Therapeutics, Inc. $VERA
Pictet Asset Management Holding SA cut its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 3.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,392,421 shares of the company's stock after sellin...
MarketBeat
Vera Therapeutics (VERA) to Release Earnings on Tuesday
Vera Therapeutics (NASDAQ:VERA) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat
Vera Therapeutics (NASDAQ:VERA) CEO Marshall Fordyce Sells 22,951 Shares
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) CEO Marshall Fordyce sold 22,951 shares of the company's stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of $44.05, for a total value of $1,010,991.55. Following the completion of the transaction, the...
MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Analysts
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and t...
MarketBeat
Vera Therapeutics (NASDAQ:VERA) CEO Sells $1,010,991.55 in Stock
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) CEO Marshall Fordyce sold 22,951 shares of the company's stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of $44.05, for a total value of $1,010,991.55. Following the transaction, the chief executive...
MarketBeat
AMI Asset Management Corp Makes New $1.44 Million Investment in Vera Therapeutics, Inc. $VERA
AMI Asset Management Corp bought a new position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 7.1% - What's Next?
Vera Therapeutics (NASDAQ:VERA) Trading Up 7.1% - Here's What Happened...
MarketBeat
JPMorgan Chase & Co. Sells 228,182 Shares of Vera Therapeutics, Inc. $VERA
JPMorgan Chase & Co. cut its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 73.5% in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat
E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA
E. Ohman J or Asset Management AB purchased a new stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the fourth quarter, according to the company in its most recent 13F...
MarketBeat
<
1
2
...
>